Medicus Pharma (MDCX) Competitors $2.67 -0.32 (-10.70%) As of 01/21/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsSEC FilingsTrends MDCX vs. TELO, CLYM, XBIT, ANRO, NVCT, MIST, IVA, ATOS, PEPG, and ENTAShould you be buying Medicus Pharma stock or one of its competitors? The main competitors of Medicus Pharma include Telomir Pharmaceuticals (TELO), Climb Bio (CLYM), XBiotech (XBIT), Alto Neuroscience (ANRO), Nuvectis Pharma (NVCT), Milestone Pharmaceuticals (MIST), Inventiva (IVA), Atossa Therapeutics (ATOS), PepGen (PEPG), and Enanta Pharmaceuticals (ENTA). These companies are all part of the "pharmaceutical preparations" industry. Medicus Pharma vs. Telomir Pharmaceuticals Climb Bio XBiotech Alto Neuroscience Nuvectis Pharma Milestone Pharmaceuticals Inventiva Atossa Therapeutics PepGen Enanta Pharmaceuticals Telomir Pharmaceuticals (NASDAQ:TELO) and Medicus Pharma (NASDAQ:MDCX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, community ranking, media sentiment, risk, analyst recommendations, institutional ownership and dividends. Does the MarketBeat Community favor TELO or MDCX? Medicus Pharma received 2 more outperform votes than Telomir Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformTelomir PharmaceuticalsN/AN/AMedicus PharmaOutperform Votes2100.00% Underperform VotesNo Votes Do analysts recommend TELO or MDCX? Medicus Pharma has a consensus target price of $10.00, indicating a potential upside of 274.53%. Given Medicus Pharma's stronger consensus rating and higher possible upside, analysts clearly believe Medicus Pharma is more favorable than Telomir Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Telomir Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Medicus Pharma 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Which has better valuation and earnings, TELO or MDCX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTelomir PharmaceuticalsN/AN/A-$13.07MN/AN/AMedicus PharmaN/AN/AN/AN/AN/A Is TELO or MDCX more profitable? Medicus Pharma's return on equity of 0.00% beat Telomir Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Telomir PharmaceuticalsN/A -1,087.92% -806.34% Medicus Pharma N/A N/A N/A Does the media refer more to TELO or MDCX? In the previous week, Telomir Pharmaceuticals and Telomir Pharmaceuticals both had 1 articles in the media. Telomir Pharmaceuticals' average media sentiment score of 1.93 beat Medicus Pharma's score of 0.00 indicating that Telomir Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Telomir Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Medicus Pharma 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryMedicus Pharma beats Telomir Pharmaceuticals on 7 of the 8 factors compared between the two stocks. Get Medicus Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDCX vs. The Competition Export to ExcelMetricMedicus PharmaPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$32.43M$6.57B$5.39B$9.13BDividend YieldN/A2.96%5.37%4.00%P/E RatioN/A10.0189.0817.53Price / SalesN/A329.781,255.34136.91Price / CashN/A22.6336.6032.90Price / BookN/A5.084.964.69Net IncomeN/A$154.90M$117.89M$224.57M7 Day Performance3.49%1.33%1.72%1.69%1 Month Performance3.49%1.51%3.66%5.34%1 Year PerformanceN/A4.60%25.79%21.47% Medicus Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDCXMedicus PharmaN/A$2.67-10.7%$10.00+274.5%N/A$32.43MN/A0.00N/AGap DownTELOTelomir PharmaceuticalsN/A$4.30-5.5%N/AN/A$127.32MN/A0.001Gap DownCLYMClimb Bio3.4357 of 5 stars$1.87-10.5%$10.00+434.8%N/A$125.71MN/A-0.88N/AGap UpXBITXBiotech0.588 of 5 stars$4.01-5.9%N/A-17.6%$122.24M$4.01M-3.71100ANROAlto Neuroscience2.5878 of 5 stars$4.43-2.0%$20.00+351.5%N/A$121.90M$210,000.000.00N/ANVCTNuvectis Pharma2.9877 of 5 stars$6.17-1.0%$21.00+240.4%-30.3%$119.21MN/A-5.328Positive NewsMISTMilestone Pharmaceuticals2.3536 of 5 stars$2.20-0.9%$13.00+490.9%+52.9%$117.32M$1M-2.7230Positive NewsIVAInventiva2.6256 of 5 stars$2.22flat$13.25+496.8%-43.3%$116.50M$15.62M0.00100Positive NewsATOSAtossa Therapeutics1.2039 of 5 stars$0.92-2.8%$7.00+657.0%+6.1%$116.33MN/A-4.208PEPGPepGen3.0465 of 5 stars$3.45-1.1%$13.67+296.1%-69.1%$112.46MN/A-1.1672ENTAEnanta Pharmaceuticals4.4057 of 5 stars$5.16-4.3%$17.25+234.3%-56.3%$109.36M$67.64M-0.94145Positive NewsGap Down Related Companies and Tools Related Companies Telomir Pharmaceuticals Alternatives Climb Bio Alternatives XBiotech Alternatives Alto Neuroscience Alternatives Nuvectis Pharma Alternatives Milestone Pharmaceuticals Alternatives Inventiva Alternatives Atossa Therapeutics Alternatives PepGen Alternatives Enanta Pharmaceuticals Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MDCX) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicus Pharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicus Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDCX Stock Alerts